Biotechnology

Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis

by

– Preclinical Data Published in the Peer-Reviewed Journal of Medicinal Chemistry Identifies Vidofludimus Calcium as a Potent Nurr1 Activator – – Nurr1 Activation Suggested to Prevent Neurodegeneration Which is Relevant in Multiple Sclerosis, Parkinson’s Disease and Beyond – NEW YORK, May 17, 2023 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline … Read more

New Clarivate Biopharma Dealmaking Report Reveals Investment Patterns Set to Impact the Future of Medicine

by

Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning among key areas of investment for pharma LONDON, May 17, 2023 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023.  This year’s report … Read more

New Clarivate Biopharma Dealmaking Report Reveals Investment Patterns Set to Impact the Future of Medicine

by

Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning among key areas of investment for pharma LONDON, May 17, 2023 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023.  This year’s report … Read more

Inclusion of Recbio In the MSCI China Small Cap Index

by

TAIZHOU, China, May 17, 2023 /PRNewswire/ — Jiangsu Recbio Technology Co., Ltd. (the “Company”, together with its subsidiaries, the “Group”) is pleased to announce that, MSCI announced the results of the semi-annual review of the MSCI Global Small Cap Indexes on May 12, 2023, and the Company has been selected as a constituent of the … Read more